{"id":537703,"date":"2021-04-09T13:16:01","date_gmt":"2021-04-09T13:16:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=537703"},"modified":"2021-04-09T13:16:01","modified_gmt":"2021-04-09T13:16:01","slug":"oncolytic-virus-therapy-market-applications-future-trends-recent-demand-growth-analysis-insights-outlook-size-and-forecasts-report-2027","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/oncolytic-virus-therapy-market-applications-future-trends-recent-demand-growth-analysis-insights-outlook-size-and-forecasts-report-2027_537703.html","title":{"rendered":"Oncolytic Virus Therapy Market Applications, Future Trends, Recent Demand, Growth Analysis, Insights, Outlook, Size and Forecasts Report 2027"},"content":{"rendered":"
The study methodologies used to examine the Oncolytic Virus Therapy market for the forecast period, 2020 – 2027 further classifies the industry by type, geography, end-use and end-user to add more precision and bring to light factors responsible for augmenting business development.<\/div>\n

The global oncolytic virus therapy market size is expected to reach USD 866.1 Million at a steady CAGR of 23.9% in 2028, according to latest analysis by Emergen Research. Steady growth of oncolytic virus therapy market can be attributed to rising cancer incidence globally. Cancer is a major cause of deaths in countries across the globe and it is estimated that in 2020, over 1.8 million new cancer cases were diagnosed in the US, with over 0.6 Million deaths occurring due to the disease.<\/p>\n

Also, around 70% of cancer mortality occurs in low and middle-income countries. Oncolytic virus therapy (a type of immunotherapy) uses engineered viruses to destroy cancer cells without affecting healthy cells in the human body. Once a cancer cell is destroyed, it releases cancer antigens that trigger immune responses to destroy other tumor cells in the body.<\/p>\n

This report studies the global Oncolytic Virus Therapy market status and forecast, categorizes the global Oncolytic Virus Therapy market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).<\/p>\n

You Can Download Free Sample PDF Copy of Oncolytic Virus Therapy Market at https:\/\/www.emergenresearch.com\/request-sample\/541<\/a><\/strong><\/p>\n

The North America oncolytic virus therapy accounted for largest revenue share in the global oncolytic virus therapy market in 2020, which can be attributed to rising incidence of cancer, particularly among the elderly population. Furthermore, presence of major oncolytic virus therapy firms and rising investments in cancer immunotherapy is a major factor driving growth of the market in the region.<\/p>\n

Key players in the market include<\/strong> Oncolytics Biotech Inc., Lokon Pharma AB, PsiOxus Therapeutics, Sorrento Therapeutics Inc., CG Oncology Inc., ORYX GmbH & Co. KG, VCNBiosciences, DNAtrix, Targovax, and SillaJen Inc.<\/p>\n

Type Outlook (Revenue, USD Million; 2021–2028)<\/strong><\/p>\n

Monoclonal Antibodies<\/p>\n

Checkpoint Inhibitors<\/p>\n

Cancer Vaccines<\/p>\n

Immunomodulators<\/p>\n

Application Outlook (Revenue, USD Million; 2021–2028)<\/strong><\/p>\n

Melanoma<\/p>\n

Lung Cancer<\/p>\n

Breast Cancer<\/p>\n

Others<\/p>\n

End-Use Outlook (Revenue, USD Million; 2021–2028)<\/strong><\/p>\n

Hospitals<\/p>\n

Clinics<\/p>\n

Research Institutes<\/p>\n

Others<\/p>\n

You Can Download Free Sample PDF Copy of Oncolytic Virus Therapy Market at https:\/\/www.emergenresearch.com\/request-sample\/541<\/a><\/strong><\/p>\n

The subject matter experts conducting the study offer a deep understanding of how prominent leaders have managed to navigate the potential buyers and competitive dynamics influencing their brand positioning in the industry The Oncolytic Virus Therapy market analysis provides everything a business owner needs in order to succeed.<\/p>\n

Key questions answered in the report<\/strong><\/p>\n

What will be the market size in terms of value and volume in the next five years?<\/p>\n

Which segment is currently leading the market?<\/p>\n

In which region will the market find its highest growth?<\/p>\n

Which players will take the lead in the market?<\/p>\n

What are the key drivers and restraints of the market’s growth?<\/p>\n

Research Methodology<\/strong><\/p>\n

Data triangulation and market breakdown<\/p>\n

Research assumptions Research data including primary and secondary data<\/p>\n

Primary data includes breakdown of primaries and key industry insights<\/p>\n

Secondary data includes key data from secondary sources<\/p>\n

The Oncolytic Virus Therapy report highlights set of information related to pricing and the category of customers who are more than willing to pay for certain products and services. The information on opportunities as well as product features, determine which offerings or benefits command sale and identify the communications channels used by the  market leaders to create premium positioning strategies  as well as attract broadest share.<\/p>\n

Read more@ https:\/\/www.emergenresearch.com\/industry-report\/oncolytic-virus-therapy-market<\/a><\/strong><\/p>\n

Table of content:<\/strong><\/p>\n

Chapter 1. Methodology & Sources<\/p>\n

    1.1. Market Definition<\/p>\n

    1.2. Research Scope<\/p>\n

    1.3. Methodology<\/p>\n

    1.4. Research Sources<\/p>\n

          1.4.1. Primary<\/p>\n

          1.4.2. Secondary<\/p>\n

          1.4.3. Paid Sources<\/p>\n

    1.5. Market Estimation Technique<\/p>\n

Chapter 2. Executive Summary<\/p>\n

    2.1. Summary Snapshot, 2019-2027<\/p>\n

Chapter 3. Key Insights<\/p>\n

Chapter 4. Oncolytic Virus Therapy Market Segmentation & Impact Analysis<\/p>\n

    4.1. Oncolytic Virus Therapy Market Material Segmentation Analysis<\/p>\n

    4.2. Industrial Outlook<\/p>\n

          4.2.1. Market indicators analysis<\/p>\n

          4.2.2. Market drivers analysis<\/p>\n

                    4.2.2.1. Growing demand for growing medicinal application<\/p>\n

                    4.2.2.2. Rising legalization of Oncolytic Virus Therapy<\/p>\n

                    4.2.2.3. Technological advancement in product invention<\/p>\n

          4.2.3. Market restraints analysis<\/p>\n

                    4.2.3.1. The complex regulatory framework for the usage of Oncolytic Virus Therapy<\/p>\n

    4.3. Technological Insights<\/p>\n

    4.4. Regulatory Framework<\/p>\n

    4.5. Porter’s Five Forces Analysis<\/p>\n

    4.6. Competitive Metric Space Analysis<\/p>\n

    4.7. Price trend Analysis<\/p>\n

    4.8. Covid-19 Impact Analysis<\/p>\n

Continued…<\/strong><\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Emergen Research<\/a>
Contact Person:<\/strong> Eric Lee
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +1 (604) 757-9756
Address:<\/strong>14671 110 Avenue Surrey, British Columbia, V3R2A9
City:<\/strong> Surrey
State:<\/strong> British Columbia
Country:<\/strong> Canada
Website:<\/strong> https:\/\/www.emergenresearch.com\/industry-report\/oncolytic-virus-therapy-market<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

The study methodologies used to examine the Oncolytic Virus Therapy market for the forecast period, 2020 – 2027 further classifies the industry by type, geography, end-use and end-user to add more precision and bring to light factors responsible for augmenting … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[435,405,406,403,404],"tags":[],"class_list":["post-537703","post","type-post","status-publish","format-standard","hentry","category-Europe","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-UK","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/537703","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=537703"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/537703\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=537703"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=537703"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=537703"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}